Prostate Adenocarcinoma
Showing 1 - 25 of 187
Prospective Androgen Receptor Signaling Inhibitors Resistance
Not yet recruiting
- Prostate Cancer
- +3 more
- (no location specified)
Nov 15, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
dapted Strategy Including Magnetic Resonance Imaging and
Completed
- Prostate Cancer
- Prostate Adenocarcinoma
-
Ankara, TurkeyAnkara University School of Medicine
Sep 6, 2023
Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)
Not yet recruiting
- Prostate Adenocarcinoma
- Biopsy
- +3 more
-
Los Angeles, California
- +4 more
Sep 7, 2023
Prostate Adenocarcinoma Trial in Fuzhou (Personalized Optimization of Systematic Prostate Biopsy)
Recruiting
- Prostate Adenocarcinoma
- Personalized Optimization of Systematic Prostate Biopsy
-
Fuzhou, Fujian, ChinaDepartment of Urology, Fujian Union Hospital, Fujian Medical Uni
Aug 16, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Alkmaar, Netherlands
- +27 more
Jun 27, 2023
Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate SBRT (stereotactic body radiation therapy) with focal boost
-
Madrid, SpainLa Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a
Recruiting
- Prostate Cancer
- +4 more
- Performing cognitive prostate biopsy with a radiologist's guidance with map
- Performing cognitive prostate biopsy without a radiologist's guidance with map
-
Istanbul, TurkeyMarmara University, School of Medicine, Department of Urology
Jun 5, 2023
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Biopsy of Prostate
- +6 more
-
Chicago, IllinoisNorthwestern University
May 9, 2023
Prostate Adenocarcinoma Trial in Duarte, Los Angeles, Durham (Fasting Mimicking Diet (FMD), Usual Diet)
Not yet recruiting
- Prostate Adenocarcinoma
- Fasting Mimicking Diet (FMD)
- Usual Diet
-
Duarte, California
- +2 more
Apr 27, 2023
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)
Completed
- Prostate Disease
- +6 more
- Self-Administered Nitrous Oxide
- Oxygen
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 25, 2023
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)
Not yet recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Furosemide
- +3 more
-
Atlanta, Georgia
- +3 more
Mar 9, 2023
Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in United States (Exercise Therapy)
Recruiting
- Prostate Cancer
- +2 more
- Exercise Therapy
-
Los Angeles, California
- +7 more
Feb 20, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Columbia (Ga-68-PSMA-11)
Terminated
- Prostate Cancer
- Prostate Adenocarcinoma
-
Columbia, MissouriTruman VA Hospital
Feb 15, 2023
Prostate Adenocarcinoma, Incontinence Stress, Erectile Dysfunction Following Radical Prostatectomy Trial in Miami (Maximal
Completed
- Prostate Adenocarcinoma
- +2 more
- Maximal urethral length preservation technique of robot assisted radical prostatectomy (RALP).
-
Miami, FloridaLarkin Health System
Feb 17, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- 18F-DCFPyL
- Stereotactic Body Radiation Therapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (other, radiation, procedure)
Not yet recruiting
- Prostate Cancer
- +2 more
- Risk Map Decision Support System (DSS).
- +2 more
- (no location specified)
Jan 25, 2023
Prostate Adenocarcinoma Trial (De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac)
Not yet recruiting
- Prostate Adenocarcinoma
- De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac
- (no location specified)
Jan 23, 2023
Adding MR Fusion to Standard US Guided Prostate Biopsy
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- TRUS biopsy
-
Tucson, ArizonaUniversity of Arizona
Jan 27, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Durvalumab
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023